Summary
For Year 2026-27, Solara Active Pharma Sciences reports the following shareholding: Total Promoters at 42%, Mutual Fund at 1.18%, Insurance at 0%, Foreign Institutional Investors at 11.59%, Domestic Institutional Investors at 2.57%, and Retail at 42.66%. This breakdown provides a quick snapshot of ownership distribution for Solara Active Pharma Sciences in 2026-27.
Solara Active Pharma Sciences FAQs
As of 04-2026, the promoter shareholding in Solara Active Pharma Sciences stands at 42% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Solara Active Pharma Sciences is 11.59% and 2.57% respectively.
The retail shareholding of the Solara Active Pharma Sciences is 42.66%.
Changes in shareholding patterns of Solara Active Pharma Sciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Solara Active Pharma Sciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Solara Active Pharma Sciences Associated Pages
- Solara Active Pharma Sciences Share Price
- Solara Active Pharma Sciences Share Price chart
- Solara Active Pharma Sciences Fundamental Analysis
- Solara Active Pharma Sciences Technical Analysis
- Solara Active Pharma Sciences Peer Comparison
- Solara Active Pharma Sciences Share Price History
- Solara Active Pharma Sciences Board of Directors
